What is CONMED's revenue?

CONMED (CNMD) generated $1.4B in revenue over the trailing twelve months, up 4.1% year over year.

Is CONMED profitable?

CONMED reported $54.8M in net income over the trailing twelve months, a 4.0% net margin.

What are CONMED's profit margins?

Gross margin is 55.2% and operating margin is 8.2%, with a 4.0% net margin.

What is CONMED's earnings per share?

CONMED's diluted EPS over the trailing twelve months is $1.77.

Where does CONMED's income statement data come from?

Every line is extracted from CONMED's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

CONMED CNMD Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Total revenue	$317.05M-15.0%	$373.2M+10.4%	$337.93M-1.3%	$342.35M+6.6%	$321.26M-7.1%
Total cost of revenue	$133.6M-13.8%	$154.91M-9.8%	$171.81M+11.5%	$154.03M+7.3%	$143.5M-2.8%
Gross profit	$183.45M-16.0%	$218.29M+31.4%	$166.12M-11.8%	$188.32M+5.9%	$177.75M-10.4%
Gross margin	57.9%-0.6pp	58.5%+9.3pp	49.2%-5.9pp	55%-0.3pp	55.3%-2.0pp
Research and development	$16.33M+9.6%	$14.9M+7.2%	$13.9M-1.7%	$14.14M+9.2%	$12.95M-1.7%
Selling, general and administrative	$141.7M-15.0%	$166.76M+18.8%	$140.34M+3.2%	$136.02M-8.6%	$148.85M+12.2%
Selling and marketing	$18.11M+3.7%	$17.47M+3.3%	$16.92M-0.5%	$16.99M+7.0%	$15.87M-8.4%
General and administrative	$32.4M-5.7%	$34.35M+7.6%	$31.94M-3.3%	$33.02M+1.1%	$32.66M+16.3%
Total operating expenses	$158.03M-13.0%	$181.66M+17.8%	$154.24M+2.7%	$150.16M-7.2%	$161.79M+10.9%
Operating income	$25.42M-30.6%	$36.62M+208%	$11.88M-68.9%	$38.16M+139%	$15.96M-69.6%
Operating margin	8%-1.8pp	9.8%+6.3pp	3.5%-7.6pp	11.1%+6.2pp	5%-10.2pp
Interest expense	$7.06M-4.2%	$7.37M-3.1%	$7.61M-2.8%	$7.82M-5.6%	$8.29M-6.4%
Other income (expense), net	$828K+20,600%	$4K-97.3%	$147K-69.6%	$483K+204%	-$464K-326%
Income before income taxes	$18.36M-37.3%	$29.25M+585%	$4.27M-85.7%	$29.92M+290%	$7.67M-82.4%
Income tax expense	$4.53M-63.8%	$12.51M+785%	$1.41M-83.4%	$8.5M+419%	$1.64M-83.5%
Net income	$13.83M-17.4%	$16.74M+485%	$2.86M-86.7%	$21.42M+255%	$6.04M-82.1%
Net margin	4.4%-0.1pp	4.5%+3.6pp	0.8%-5.4pp	6.3%+4.4pp	1.9%-7.9pp
Diluted earnings per share	$0.45-16.7%	$0.54+500%	$0.09-87.0%	$0.69+263%	$0.19-82.4%
EBITDA	$38.29M-23.1%	$49.79M+99.5%	$24.96M-51.4%	$51.33M+77.6%	$28.89M-55.8%
EBITDA margin	12.1%-1.3pp	13.3%+6.0pp	7.4%-7.6pp	15%+6.0pp	9%-9.9pp
EBIT	$25.42M-30.6%	$36.62M+208%	$11.88M-68.9%	$38.16M+139%	$15.96M-69.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about CONMED.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CONMED's revenue?: CONMED (CNMD) generated $1.4B in revenue over the trailing twelve months, up 4.1% year over year.
Is CONMED profitable?: CONMED reported $54.8M in net income over the trailing twelve months, a 4.0% net margin.
What are CONMED's profit margins?: Gross margin is 55.2% and operating margin is 8.2%, with a 4.0% net margin.
What is CONMED's earnings per share?: CONMED's diluted EPS over the trailing twelve months is $1.77.
Where does CONMED's income statement data come from?: Every line is extracted from CONMED's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.